Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034
상품코드:1769580
리서치사:The Business Research Company
발행일:2025년 07월
페이지 정보:영문 326 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 화학요법 유발성 말초신경병증 치료 시장은 2019년 12억 7,808만 달러로 평가되었으며 2024년까지 연평균 복합 성장률(CAGR) 5.00% 이상을 나타낼 전망입니다.
통증 관리 요법의 채용 증가
과거에는 통증 관리 요법의 채용이 증가하여 화학요법 유발성 말초신경병증 치료 시장 성장을 지원했습니다. 환자의 결과를 향상시키고 CIPN에 특화된 치료법의 폭넓은 이용을 지원하고 있습니다. 예를 들어, 2024년 9월, 일본을 거점으로 하는 독립 비영리의 의료 시책 싱크 탱크인 Health and Global Policy Institute의 보고서는 일본의 통증 관리 요법의 채용이 급속히 증가하고 있음을 강조했습니다. 2023년에는 성인의 약 22.5%, 약 2,315만명이 만성 통증에 걸렸습니다. 그 때문에 통통 관리 치료의 채용이 증가하고 있어, 화학요법 유발성 말초신경병증 치료 시장 성장을 지지하고 있습니다.
목차
제1장 주요 요약
화학요법 유발성 말초신경병증 치료 - 시장 매력과 거시경제 상황
제2장 목차
제3장 표 일람
제4장 그림 일람
제5장 보고서 구성
제6장 시장 특징
일반적인 시장 정의
개요
화학요법 유발성 말초신경병증 치료 시장 정의와 세분화
시장 세분화 : 약품 클래스별
신경전달물질에 의한 요법
기타
시장 세분화 : 치료별
약
물리치료
기타
시장 세분화 : 약제 유형별
브랜드
일반
시장 세분화 : 유통 채널별
병원 약국
소매 약국
온라인 약국
기타
시장 세분화 : 최종 사용자별
병원
연구기관
전문 클리닉
제7장 주요 시장 동향
공동조사 화학요법 유발성 말초신경병증의 이해도 증가
화학요법 유발성 말초신경병증에 대한 선택적 FABP5 억제제의 진보
전략적 자금 제공에 의해 화학요법 관련 신경 손상에 대한 신경보호 요법이 진보
제8장 세계의 화학요법 유발성 말초신경병증 치료 성장 분석과 전략 분석 프레임워크
세계의 : PESTEL 분석
정치
경제
사회
기술
환경
법률
최종 사용자(B2B) 시장 분석
병원
연구기관
전문 클리닉
세계의 화학요법 유발성 말초신경병증 치료 시장 : 성장률 분석
시장 성장 실적(2019-2024년)
시장 성장 촉진요인(2019-2024년)
시장 성장 억제요인(2019-2024년)
시장 성장 예측(2024-2029년, 2034년)
성장 예측의 공헌 요인
양적 성장의 공헌 요인
성장 촉진요인
성장 억제요인
화학요법 유발성 말초신경병증 치료 : 전체 시장(TAM)
제9장 세계의 화학요법 유발성 말초신경병증 치료 시장 : 세분화
세계의 화학요법 유발성 말초신경병증 치료 시장 : 약제 클래스별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 치료별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 약제 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 신경전달물질 기반 치료 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 기타 약제 클래스 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
제10장 화학요법 유발성 말초신경병증 치료 시장 : 지역 및 국가별 분석
세계의 화학요법 유발성 말초신경병증 치료 시장 : 지역별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장 : 국가별, 분석과 예측(2019-2024년, 2029년, 2034년)
세계의 화학요법 유발성 말초신경병증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
세계의 화학요법 유발성 말초신경병증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
세계의 화학요법 유발성 말초신경병증 치료 시장(2029년) : 성장 전략
시장 동향에 의한 전략
제25장 화학요법 유발성 말초신경병증 치료 시장 : 결론과 제안
결론
권고
제품
장소
가격
프로모션
인재
제26장 부록
KTH
영문 목차
영문목차
Chemotherapy induced peripheral neuropathy (CIPN) treatment encompasses a range of therapeutic interventions aimed at alleviating the nerve damage caused by certain chemotherapeutic agents. CIPN manifests as a dose-limiting side effect in approximately 30-40% of patients undergoing chemotherapy, leading to symptoms such as pain, tingling and numbness, primarily in the hands and feet. The treatments are utilized by oncologists, neurologists, pain specialists and primary care physicians to manage these symptoms and improve patient quality of life during and after cancer therapy.
The global chemotherapy induced peripheral neuropathy treatment market was valued at $1,278.08 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 5.00%.
Rising Adoption Of Pain Management Therapies
During the historic period, the rising adoption of pain management therapies supported the growth of the CIPN treatment market. Chemotherapy-Induced Peripheral Neuropathy (CIPN) presents substantial pain and discomfort, prompting increasing interest from both patients and healthcare providers in specialized pain management solutions. The adoption of multimodal treatment strategies-combining pharmacological options such as anticonvulsants and antidepressants with physical therapy and complementary interventions-enhances patient outcomes and supports wider utilization of CIPN-specific therapies. Moreover, successful pain control enables patients to maintain chemotherapy regimens with fewer dose modifications or interruptions, underscoring the critical role of CIPN treatments within comprehensive pain management. For instance, in September 2024, a report by the Health and Global Policy Institute, a Japan-based independent, non-profit health policy think tank, highlighted that the adoption of pain management therapies in Japan is rapidly rising. This trend is primarily driven by the country's aging population and the high prevalence of chronic pain, which affected approximately 22.5% of adults, or around 23.15 million people, in 2023. Therefore, the rising adoption of pain management therapies supported the growth of the CIPN treatment market
Collaborative Research Enhances Understanding Of Chemotherapy-Induced Peripheral Neuropathy
Major companies operating in the CIPN treatment market are adopting collaborative research initiative approach to develop advanced solutions. Strategic partnerships help CIPN treatment companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach and accelerating commercialization, ultimately driving innovation and growth in the CIPN treatment industry. For instance, in July 2025, University of Dundee, a UK-based research university partnered with Eli Lilly and Company, a US-based pharmaceutical company and Versus Arthritis, a UK-based charity focused on supporting individuals with arthritis and musculoskeletal conditions to successfully complete the research phase of the PAINSTORM Dundee Chemotherapy-Induced Peripheral Neuropathy (CIPN) Study. This collaborative effort focused on understanding the causes and progression of CIPN in cancer patients undergoing neurotoxic chemotherapy. The study involved around 200 participants, employing a multifaceted approach that includes quantitative sensory testing, blood biomarker analysis and optional magnetic resonance imaging (MRI) scans. The research aims to identify genetic, clinical and psychosocial risk factors contributing to CIPN, with the ultimate goal of informing personalized prevention and treatment strategies.
The global chemotherapy induced peripheral neuropathy treatment market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 33.13% of the total market in 2023.
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global chemotherapy induced peripheral neuropathy treatment market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for chemotherapy induced peripheral neuropathy treatment? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The chemotherapy induced peripheral neuropathy treatment market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider chemotherapy induced peripheral neuropathy treatment market; and compares it with other markets.
The report covers the following chapters
Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by drug class, by treatment, by drug type, by distribution channel and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by drug class, by treatment, by drug type, by distribution channel and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for chemotherapy induced peripheral neuropathy treatment providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Drug Class: Neurotransmitter-Based Therapy; Other Drug Classes
2) By Treatment: Medication; Physical Therapy; Other Treatments
3) By Drug Type: Branded; Generic
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Research Institutes; Specialty Clinics
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; chemotherapy induced peripheral neuropathy treatment indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
8.7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Total Addressable Market (TAM)
9 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Segmentation
9.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Distribution Channel, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.6 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Sub-Segmentation Of Neurotransmitter Based Therapy, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.7 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10 Chemotherapy Induced Peripheral Neuropathy Treatment Market, Regional and Country Analysis
10.1 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Chemotherapy Induced Peripheral Neuropathy Treatment Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Chemotherapy Induced Peripheral Neuropathy Treatment Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Major Companies
11.10 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.11 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.12 China Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.15 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.16 India Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Major Companies
11.20 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.23 South Korea Market
11.24 Summary
11.25 Market Overview
11.25.1 Country Information
11.25.2 Market Information
11.25.3 Background Information
11.25.4 Government Initiatives
11.25.5 Regulations
11.25.6 Regulatory Bodies
11.25.7 Major Associations
11.25.8 Taxes Levied
11.25.9 Corporate Tax Structure
11.25.10 Investments
11.25.11 Major Companies
11.26 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.27 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.28 South Korea Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.29 Australia Market
11.30 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.31 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.32 Australia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.33 Indonesia Market
11.34 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.35 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.36 Indonesia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate Tax Structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 UK Market
12.7 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.8 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 Germany Market
12.11 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 France Market
12.15 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 France Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Italy Market
12.19 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 Spain Market
12.23 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major Companies
13.3 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 Russia Market
13.7 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.8 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Chemotherapy Induced Peripheral Neuropathy Treatment Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Investments
14.15.11 Major Companies
14.16 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Major Companies
15.3 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.6 Brazil Market
15.7 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.8 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Major Companies
16.3 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Class, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Treatment, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Chemotherapy Induced Peripheral Neuropathy Treatment Market, Segmentation By Drug Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
